Eli Lilly Zyprexa Class Action Lawsuit Appeal Petition Rejected By The United States Supreme Court.
An appeal of a 2nd Circuit decision in a class action lawsuit against Eli Lilly (“Eli Lilly” or “Lilly” or “Defendant”) (styled Sergeants Benevolent Association Health and Welfare Fund v. Eli Lilly, 10-1173) alleging that insurers and other benefit providers overpaid for Ely Lilly’s antipsychotic drug Zyprexa, reportedly will not be considered by the U.S. Supreme Court, according to Eli Lilly Zyprexa class action lawsuit news reports.
If You Have Thoughts On The Eli Lilly Zyprexa Class Action Lawsuit, Share Your Class Action Comments Below.
Our pharmacy said the script for 30day/30 pills cost our provider
$1000…that’s ridiculus